Protex Healthcare (Uk) Ltd |
Registered Number:09132651 |
For the year ended 30 December 2022
England and Wales
Unaudited Financial Statements
For the year ended 30 December 2022
Protex Healthcare (Uk) Ltd
Contents Page
1
Statement of Financial Position
2 to 6
Notes to the Financial Statements
Protex Healthcare (Uk) Ltd
Statement of Financial Position
2021
2022
40,603
550
2
Property, plant and equipment |
1,036
3,929
3
110,992
110,992
4
152,631
115,471
Trade and other receivables |
336,520
359,523
5
83
Cash and cash equivalents |
1,794
361,317
336,603
Trade and other payables: amounts falling due within one |
year |
(270,880)
(204,680)
6
65,723
156,637
Net current assets
Total assets less current liabilities |
309,268
181,194
Trade and other payables: amounts falling due after more |
than one year |
(859,650)
(1,042,016)
7
(11,749)
(11,749)
Provisions for liabilities |
(744,497)
Net liabilities
(690,205)
147
150
581,327
558,808
(1,325,971)
(1,249,163)
(744,497)
(690,205)
Shareholders' funds
For the year ended 30 December 2022 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies. |
The members have not required the company to obtain an audit of its financial statements for the year ended 30 December 2022 in accordance with Section 476 of the Companies Act 2006 |
The directors acknowledge their responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of |
each financial year and of its profit or loss for each financial year in accordance with the requirements of Section |
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial |
statements, so far as applicable to the company. |
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. |
1 of 6
For the year ended 30 December 2022
Protex Healthcare (Uk) Ltd
Statement of Financial Position Continued
VIAENE, Dominiek Noel Director |
These financial statements were approved and authorised for issue by the Board on 29 September 2023 and were signed by: |
The notes form part of these financial statements |
2 of 6
For the year ended 30 December 2022
Protex Healthcare (Uk) Ltd
Notes to the Financial Statements
Statutory Information
Protex Healthcare (Uk) Ltd is a private limited company, limited by shares, domiciled in England and Wales, |
registration number 09132651. |
Innovation Centre
Gallows Hill
Warwick
CV34 6UW
The presentation currency is £ sterling. |
Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A of Financial |
Reporting Standard 102 ''The Financial Reporting Standard applicable in the UK and Republic of Ireland'' and the |
Companies Act 2006. The financial statements have been prepared under the historical costs convention as |
modified by the revaluation of certain assets. |
The Directors have confirmed that they will continue to ensure that the company has adequate funding to meet its |
obligations as they fall due for a period 12 months from the date of approval of these financial statements. |
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax or other similar sales taxes. |
Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairments losses. Patents and licences are being amortised evenly over their estimated useful life of ten years. |
Property, plant and equipment
Property, plant and equipment, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis: |
Plant and Machinery
Computer Equipment
Inventories
Inventories are value at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. |
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date. |
3 of 6
For the year ended 30 December 2022
Protex Healthcare (Uk) Ltd
Notes to the Financial Statements Continued
2. Intangible fixed assets |
2,000
43,183
45,183
1,450
3,130
Charge for year
4,580
40,603
550
3. Property, plant and equipment |
14,309
2,585
11,724
11,724
2,585
14,309
Provision for depreciation and impairment |
10,380
1,098
9,282
Charge for year
2,893
451
2,442
13,273
1,549
11,724
-
1,036
1,036
2,442
1,487
3,929
4 of 6
For the year ended 30 December 2022
Protex Healthcare (Uk) Ltd
Notes to the Financial Statements Continued
4. Investments held as fixed assets |
110,992
110,992
110,992
110,992
110,992
110,992
110,992
110,992
5. Trade and other receivables |
2021
2022
84,171
-
275,352
336,520
336,520
359,523
The debtors above include the following amounts falling due after more than one year: |
269,824
242,120
6. Trade and other payables: amounts falling due within one year |
2021
2022
Bank loans and overdraft (secured) |
10,000
10,000
28,527
23,864
62,073
124,056
104,080
112,960
204,680
270,880
5 of 6
For the year ended 30 December 2022
Protex Healthcare (Uk) Ltd
Notes to the Financial Statements Continued
7. Trade and other payables: amounts falling due after more than one year |
2021
2022
Bank loans and overdraft (secured) |
28,820
40,000
1,013,196
819,650
1,042,016
859,650
8. Average number of persons employed |
During the year the average number of employees was 0
6 of 6